
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer
Sharanya Sivanand, Matthew G. Vander Heiden
Cancer Cell (2020) Vol. 37, Iss. 2, pp. 147-156
Open Access | Times Cited: 349
Sharanya Sivanand, Matthew G. Vander Heiden
Cancer Cell (2020) Vol. 37, Iss. 2, pp. 147-156
Open Access | Times Cited: 349
Showing 26-50 of 349 citing articles:
Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson’s disease
Yi Zhang, Xiaoqin He, Yiwei Qian, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 45
Yi Zhang, Xiaoqin He, Yiwei Qian, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 45
Regulation of Ferroptosis by Amino Acid Metabolism in Cancer
Jian Yang, Xinyu Dai, Huanji Xu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1695-1705
Open Access | Times Cited: 44
Jian Yang, Xinyu Dai, Huanji Xu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1695-1705
Open Access | Times Cited: 44
PFKP alleviates glucose starvation-induced metabolic stress in lung cancer cells via AMPK-ACC2 dependent fatty acid oxidation
Jiaqing Chen, Li Zou, Guang Lu, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Jiaqing Chen, Li Zou, Guang Lu, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 44
A Metabolic Reprogramming Amino Acid Polymer as an Immunosurveillance Activator and Leukemia Targeting Drug Carrier for T‐Cell Acute Lymphoblastic Leukemia
Changzheng Li, Xinru You, Xi Xu, et al.
Advanced Science (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 43
Changzheng Li, Xinru You, Xi Xu, et al.
Advanced Science (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 43
Amino acid metabolism, redox balance and epigenetic regulation in cancer
Xiang Li, Hongsheng Zhang
FEBS Journal (2023) Vol. 291, Iss. 3, pp. 412-429
Open Access | Times Cited: 37
Xiang Li, Hongsheng Zhang
FEBS Journal (2023) Vol. 291, Iss. 3, pp. 412-429
Open Access | Times Cited: 37
AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer
Zikun Ma, Zhiyong Li, Yize Mao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Zikun Ma, Zhiyong Li, Yize Mao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Branched-chain keto acids inhibit mitochondrial pyruvate carrier and suppress gluconeogenesis in hepatocytes
Kiyoto Nishi, Akira Yoshii, Lauren Abell, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112641-112641
Open Access | Times Cited: 26
Kiyoto Nishi, Akira Yoshii, Lauren Abell, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112641-112641
Open Access | Times Cited: 26
Branched-chain amino acids catabolism and cancer progression: focus on therapeutic interventions
Xu Er, Bangju Ji, Ketao Jin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 26
Xu Er, Bangju Ji, Ketao Jin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 26
The bidirectional relationship between metabolism and cell cycle control
Frances F. Diehl, Kiera M. Sapp, Matthew G. Vander Heiden
Trends in Cell Biology (2023) Vol. 34, Iss. 2, pp. 136-149
Closed Access | Times Cited: 25
Frances F. Diehl, Kiera M. Sapp, Matthew G. Vander Heiden
Trends in Cell Biology (2023) Vol. 34, Iss. 2, pp. 136-149
Closed Access | Times Cited: 25
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
Zhangyi Luo, Katherine M. Eichinger, Anju Zhang, et al.
Cancer Letters (2023) Vol. 575, pp. 216396-216396
Open Access | Times Cited: 25
Zhangyi Luo, Katherine M. Eichinger, Anju Zhang, et al.
Cancer Letters (2023) Vol. 575, pp. 216396-216396
Open Access | Times Cited: 25
Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy
Deze Zhao, Yu Meng, Yating Dian, et al.
Redox Biology (2023) Vol. 68, pp. 102966-102966
Open Access | Times Cited: 25
Deze Zhao, Yu Meng, Yating Dian, et al.
Redox Biology (2023) Vol. 68, pp. 102966-102966
Open Access | Times Cited: 25
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Human HDAC6 senses valine abundancy to regulate DNA damage
Jiali Jin, Tong Meng, Liang Yu, et al.
Nature (2024)
Closed Access | Times Cited: 11
Jiali Jin, Tong Meng, Liang Yu, et al.
Nature (2024)
Closed Access | Times Cited: 11
Gut microbiome-derived bacterial extracellular vesicles in patients with solid tumours
Surbhi Mishra, Mysore Vishakantegowda Tejesvi, Jenni Hekkala, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 10
Surbhi Mishra, Mysore Vishakantegowda Tejesvi, Jenni Hekkala, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 10
Metabolism-driven chromatin dynamics: Molecular principles and technological advances
Varun Sahu, Chao Lü
Molecular Cell (2025) Vol. 85, Iss. 2, pp. 262-275
Closed Access | Times Cited: 1
Varun Sahu, Chao Lü
Molecular Cell (2025) Vol. 85, Iss. 2, pp. 262-275
Closed Access | Times Cited: 1
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
Ruiyuan Xu, Jinshou Yang, Bo Ren, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 58
Ruiyuan Xu, Jinshou Yang, Bo Ren, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 58
Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression
Duc‐Vinh Pham, Pil‐Hoon Park
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1444-1444
Open Access | Times Cited: 46
Duc‐Vinh Pham, Pil‐Hoon Park
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1444-1444
Open Access | Times Cited: 46
Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma
Richard A. Noble, Huw D. Thomas, Yan Zhao, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 5, pp. 937-947
Open Access | Times Cited: 36
Richard A. Noble, Huw D. Thomas, Yan Zhao, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 5, pp. 937-947
Open Access | Times Cited: 36
COVID‐19 metabolism: Mechanisms and therapeutic targets
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 35
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 35
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases
Xinpeng Yin, Yuan Chen, Rexiati Ruze, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 35
Xinpeng Yin, Yuan Chen, Rexiati Ruze, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 35
Metabolomics and the Multi-Omics View of Cancer
David S. Wishart
Metabolites (2022) Vol. 12, Iss. 2, pp. 154-154
Open Access | Times Cited: 34
David S. Wishart
Metabolites (2022) Vol. 12, Iss. 2, pp. 154-154
Open Access | Times Cited: 34
Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus
Yang Yang, Ying Luan, Feng Qi, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 33
Yang Yang, Ying Luan, Feng Qi, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 33
The role of branched chain amino acids metabolic disorders in tumorigenesis and progression
Jingtong Wang, Wei Wang, Feng Zhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113390-113390
Open Access | Times Cited: 29
Jingtong Wang, Wei Wang, Feng Zhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113390-113390
Open Access | Times Cited: 29
Precise Metabolomics Defines Systemic Metabolic Dysregulation Distinct to Acute Myocardial Infarction Associated With Diabetes
Jinggang Xia, Bowen Li, Hao Zhang, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 4, pp. 581-596
Open Access | Times Cited: 19
Jinggang Xia, Bowen Li, Hao Zhang, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 4, pp. 581-596
Open Access | Times Cited: 19